Higher level of [3H]UCB-J binding in ApoE Ɛ4 allele carriers with Alzheimer disease
Jens Damsgaard Mikkelsen, Phoebe Linde-Atkins, Burcu Azak Pazarlar. Neuroscience Letters, 2025-02-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
H]UCB-J was found to be reduced in frontal cortex from patients with AD. We report here that the reduction in SV2A binding is highly significant only in patients not carrying the ApoE ɛ4 allele. By contrast, those individuals with one or two ApoE ɛ4 alleles had SV2A binding levels not different from controls. Because ApoE4 is an important genetic risk and strongly linked to late-onset AD, this study raises an interesting new and unexpected association to SV2A, synapse loss, and function.
What this study adds
Evidence grade: Low
The reduction in SV2A binding was highly significant only in Alzheimer's disease patients not carrying the ApoE ε4 allele, while carriers had levels not different from controls. This is an unexpected association between ApoE4, SV2A, and synapse loss, not a treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Mikkelsen, J. D., Linde-Atkins, P., & Pazarlar, B. A. (2025). Higher level of [3H]UCB-J binding in ApoE Ɛ4 allele carriers with Alzheimer disease. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2025.138135
Vancouver
Mikkelsen JD, Linde-Atkins P, Pazarlar BA. Higher level of [3H]UCB-J binding in ApoE Ɛ4 allele carriers with Alzheimer disease. Neuroscience Letters. 2025. doi:10.1016/j.neulet.2025.138135. PMID: 39900278.
BibTeX
@article{mikkelsen2025-39900278,
author = {Mikkelsen, Jens Damsgaard and Linde-Atkins, Phoebe and Pazarlar, Burcu Azak},
title = {{Higher level of [3H]UCB-J binding in ApoE Ɛ4 allele carriers with Alzheimer disease}},
journal = {Neuroscience Letters},
year = {2025},
doi = {10.1016/j.neulet.2025.138135},
pmid = {39900278},
url = {https://doi.org/10.1016/j.neulet.2025.138135}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We report here that the reduction in SV2A binding is highly significant only in patients not carrying the ApoE ɛ4 allele.
Why it matters
The reduction in SV2A binding was highly significant only in Alzheimer's disease patients not carrying the ApoE ε4 allele, while carriers had levels not different from controls. This is an unexpected association between ApoE4, SV2A, and synapse loss, not a treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuroscience Letters) |
| Journal's citation record | 3 / 4 | Neuroscience Letters: journal h-index 267 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Burcu Azak Pazarlar: h-index 7 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Copenhagen: institution h-index 1,378 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39900278) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.neulet.2025.138135
- PubMed: 39900278
- Original source →
- Free full text: Neuroscience Letters →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Genetics from nearby years
Also tagged “precursor”
1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.